Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Nov;57(11):1764-1770.
doi: 10.2967/jnumed.115.157438. Epub 2016 Sep 1.

Imaging Pulmonary Inflammation

Affiliations
Review

Imaging Pulmonary Inflammation

Philip M Scherer et al. J Nucl Med. 2016 Nov.

Abstract

Lung inflammatory diseases contribute significantly to the socioeconomic burden of disease. Yet very few new, effective therapies for respiratory disease have been approved for use. A major contributing factor is the lack of biomarkers that can accurately quantify the lung inflammatory burden and can be used to understand the contribution of lung inflammation to loss in lung function. Molecular imaging approaches can detect and quantify the recruitment and activation of specific immune cells in lung inflammation. We review the clinical techniques used to image lung inflammation, provide an overview of clinical and emerging PET techniques for quantifying lung inflammation, and discuss potential clinical applications.

Keywords: lung inflammation; molecular imaging; positron emission tomography; pulmonary.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
CT manifestations of inflammatory lung disease. (A) Organizing pneumonia is characterized by left lower lobe focal consolidation with peripheral ground-glass opacity and air bronchograms. Chronic eosinophilic pneumonia and adenocarcinoma in situ can appear similar. (B) Diffuse, confluent ground-glass opacity and interlobular septal thickening with a “crazy paving” pattern in right lung, with lesser involvement of left lung can reflect multifocal pneumonia, atypical edema pattern, or pulmonary parenchymal hemorrhage. Pleural effusions are also present bilaterally. (C) Nonspecific interstitial pneumonia exhibits predominantly peripheral ground-glass opacity with fine reticulation and subpleural sparring in lower lobes, right greater than left. Absence of honeycombing makes usual interstitial pneumonia unlikely.
FIGURE 2.
FIGURE 2.
PET/CT images in COPD and age-matched healthy volunteers in pilot study assessing reproducibility of 18F-FDG uptake in COPD lungs. (A) Representative PET and CT images from healthy volunteer and volunteers with COPD without or with chronic bronchitis symptoms. PET images shown are sum of last 5 min of data from 60-min dynamic acquisition. COPD participant without chronic bronchitis had emphysema diffusely throughout both lungs on CT. COPD participant with chronic bronchitis had more heterogeneously distributed emphysema. Units of intercept-normalized Ki (KiN) = min−1. (B) All data points in healthy volunteers (n = 7) and COPD participants without (n = 6) and with chronic bronchitis symptoms (n = 4). (Data reported in abstract form in Chen et al. (52)).
FIGURE 3.
FIGURE 3.
PET and CT images from 2 patients obtained within 24 h of being placed on ventilator. Images on left demonstrate no abnormal 18F-FDG uptake within lungs. Images on right demonstrate visibly increased 18F-FDG uptake in both lungs. SUVs of whole lung were not different between patients, demonstrating relative insensitivity of SUV for quantifying whole-lung inflammation compared with whole-lung Ki, which is higher in patient on right. Kir and SUVr are Ki and SUV in 50% of pixels with highest activity within each region of interest (in white). Images obtained in collaboration with Brian Fuller, MD, Washington University School of Medicine.
FIGURE 4.
FIGURE 4.
High-resolution CT and 18F-FDG PET/CT in usual interstitial pneumonia. (A) Axial high-resolution CT image of chest demonstrates honeycombing, fibrosis, and traction bronchiectasis, most evident in lingula. There is also emphysema. (B and C) Axial attenuation-corrected PET and fused PET/CT images demonstrate mild, diffusely increased 18F-FDG uptake throughout lung parenchy3ma, with more focally increased 18F-FDG uptake in area of honeycombing and fibrosis in lingula.
FIGURE 5.
FIGURE 5.
High-resolution CT and 18F-FDG PET/CT in ILD. (A) Coronal maximum-intensity-projection PET image demonstrates diffusely increased 18F-FDG uptake in left lung, with lesser involvement in right lung. (B and C) Axial PET and PET/CT fused images shows heterogeneously increased 18F-FDG uptake, suggesting active inflammation or possible active fibrosis. (D) CT images demonstrate regions of diffuse ground-glass opacity with honeycombing, interlobular septal thickening, and bronchiectasis, more pronounced on right, in areas of increased 18F-FDG uptake. Although usual interstitial pneumonia was suspected due to presence of honeycombing, left lung biopsies demonstrated emphysematous changes, subpleural and interstitial fibrosis, and focal organizing pneumonitis, with considerations including hypersensitivity pneumonitis or smoking-related ILD.

References

    1. National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI). Morbidity and Mortality: 2012 Chart Book on Cardiovascular, Lung, and Blood Diseases. Bethesda, MD: NHLBI; 2012.
    1. Xu JQ, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. In: National Vital Statistics Reports. Vol. 64 Hyattsville, MD: National Center for Health Statistics; 2016. - PubMed
    1. Martinez FJ, Donohue JF, Rennard SI. The future of chronic obstructive pulmonary disease treatment: difficulties of and barriers to drug development. Lancet. 2011;378:1027–1037. - PubMed
    1. Adams CP, Brantner VV. Estimating the cost of new drug development: is it really 802 million dollars? Health Aff (Millwood). 2006;25:420–428. - PubMed
    1. Grunig G, Baghdassarian A, Park SH, et al. Challenges and current efforts in the development of biomarkers for chronic inflammatory and remodeling conditions of the lungs. Biomark Insights. 2016;10:59–72. - PMC - PubMed

LinkOut - more resources